NCT00232375View on ClinicalTrials.gov

Intervention to Preserve Beta-Cell Function in GAD Ab-Positive Diabetes

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 31, 1996

Study Completion Date

January 31, 2005

Conditions
GAD Ab Positive Clinically Type 2 Diabetic Patients
Interventions
DRUG

Insulin

Trial Locations (1)

409-3898

University of Yamanashi, Tamaho

All Listed Sponsors
lead

Tokyo Study Group

OTHER

NCT00232375 - Intervention to Preserve Beta-Cell Function in GAD Ab-Positive Diabetes | Biotech Hunter | Biotech Hunter